IPP Bureau
BLS empanelled to process Ayushman Bharat cards
By IPP Bureau - September 15, 2021
The National Health Authority (NHA) aims to deliver 10 crore Ayushman Bharat cards in this financial year and extend free hospitalization benefits to 50 lakh people in a quarter
Lupin launch a generic version of pain reliever for osteoarthritis in the US
By IPP Bureau - September 15, 2021
Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21
WPO and ECR release ‘Packaging Design for Recycling Guide’
By IPP Bureau - September 15, 2021
The document is a global recommendation for circular packaging design. It will be updated and adapted to changes in the collection, sorting and recycling technology, as well as to future material development
Serum Institute to supply polio vaccine for India’s universal immunisation plan
By IPP Bureau - September 15, 2021
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
World’s first clinical trial for a rare headache disorder
By IPP Bureau - September 15, 2021
The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
By IPP Bureau - September 14, 2021
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
NHS UK gives green light to a company to detect early-stage cancer by a simple blood test
By IPP Bureau - September 14, 2021
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
ICMR to use drones for vaccine delivery
By IPP Bureau - September 14, 2021
ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland
US FDA grants Emergency Use Authorisation for Covid-19 pooled samples
By IPP Bureau - September 14, 2021
Visby Medical’s instrument-free PCR test to detect the SARS-CoV-2 virus can now be used to pool up to five patient samples using a single test
Aster MIMS Kottakal has a new wing for women and children
By IPP Bureau - September 14, 2021
It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)
Laurus Labs, Unitaid and Clinton Health Access Initiative to develop HIV medication for children
By IPP Bureau - September 14, 2021
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
By IPP Bureau - September 14, 2021
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
Prevest DenPro Limited's IPO to open on BSE SME platform on September 15
By IPP Bureau - September 14, 2021
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
ENTOD Pharma launches surgical division HyTek
By IPP Bureau - September 14, 2021
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
CSIR-NEERI transfers Saline Gargle RT-PCR technology to the MSME ministry
By IPP Bureau - September 13, 2021
This low-cost and highly reliable technology will help in increasing testing in rural and tribal areas







.png)
.jpg)
.jpg)


.jpg)


